PLEASANTON, Calif. , Aug. 8, 2024 /PRNewswire/ -- 10x Genomics, Inc.
(Nasdaq: TXG ), a leader in single cell and spatial biology, announced today several changes to its executive team. Mennah Moustafa has been named Chief Commercial Officer, effective August 1 . In this role, Moustafa will be responsible for driving commercial strategy and execution and leading the company's sales, support and marketing functions.
Justin McAnear , Chief Financial Officer, will resign from the company effective August 30 , to join a private company. Adam Taich has been appointed Chief Financial Officer, effective August 12 . Taich will be responsible for leading the company's financial team and strategy.
"For the past two years, we've been intentionally evolving the company to continue to drive strong growth at scale, with across-the-board advances in how we innovate, operate and go-to-market," said Serge Saxonov, CEO and Co-founder. "The changes we're announcing today, along with the recent additions of Alan Mateo and Sarah Teichmann to our Board of Directors, are another step forward with these efforts. While we are sad to see Justin moving on, we are excited to attract such talented and seasoned leaders to help us execute our strategy, deliver the full promise of single cell and spatial biology and capture the incredible opportunity ahead.
"Justin has been a fantastic leader, a valued partner and a trusted friend. He helped to take 10x public, scaled the company and built a strong financial.